|
Volumn 80, Issue 1, 1999, Pages 138-144
|
Tumor-growth inhibition with bispecific antibody fragments in a syngeneic mouse melanoma model: The role of targeted T-cell co-stimulation via CD28
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CD28 ANTIGEN;
IMMUNOGLOBULIN F(AB) FRAGMENT;
IMMUNOGLOBULIN FRAGMENT;
MONOCLONAL ANTIBODY CD3;
ANIMAL MODEL;
ANTIGEN BINDING;
ANTIGEN SPECIFICITY;
ARTICLE;
CANCER INHIBITION;
CANCER SURVIVAL;
CELL KILLING;
CONTROLLED STUDY;
DRUG MECHANISM;
EFFECTOR CELL;
GROWTH INHIBITION;
ISOGRAFT;
LUNG TUMOR;
MELANOMA;
MOUSE;
NONHUMAN;
PERITONEUM TUMOR;
PRIORITY JOURNAL;
T LYMPHOCYTE ACTIVATION;
TARGET CELL DESTRUCTION;
ANIMALS;
ANTIBODIES, BISPECIFIC;
ANTIGENS, CD28;
ANTIGENS, CD3;
FLUORESCENT ANTIBODY TECHNIQUE, DIRECT;
FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT;
IMMUNOGLOBULIN FAB FRAGMENTS;
LYMPHOCYTE ACTIVATION;
MELANOMA, EXPERIMENTAL;
MICE;
MICE, INBRED C57BL;
RECEPTOR-CD3 COMPLEX, ANTIGEN, T-CELL;
RECEPTORS, FC;
SPLEEN;
SURVIVAL ANALYSIS;
T-LYMPHOCYTES;
TIME FACTORS;
TUMOR CELLS, CULTURED;
|
EID: 0033524374
PISSN: 00207136
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1097-0215(19990105)80:1<138::AID-IJC25>3.0.CO;2-J Document Type: Article |
Times cited : (21)
|
References (26)
|